Literature DB >> 22030237

Participation of blood vessel cells in human adaptive immune responses.

Jordan S Pober1, George Tellides.   

Abstract

Circulating T cells contact blood vessels either when they extravasate across the walls of microvessels into inflamed tissues or when they enter into the walls of larger vessels in inflammatory diseases such as atherosclerosis. The blood vessel wall is largely composed of three cell types: endothelial cells lining the entire vascular tree; pericytes supporting the endothelium of microvessels; and smooth muscle cells forming the bulk of large vessel walls. Each of these cell types interacts with and alters the behavior of infiltrating T cells in different ways, making these cells active participants in the processes of immune-mediated inflammation. In this review, we compare and contrast what is known about the nature of these interactions in humans.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22030237      PMCID: PMC3253953          DOI: 10.1016/j.it.2011.09.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  104 in total

Review 1.  Transmigration through venular walls: a key regulator of leukocyte phenotype and function.

Authors:  Sussan Nourshargh; Federica M Marelli-Berg
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

2.  Memory T cells and their costimulators in human allograft injury.

Authors:  Stephen L Shiao; Jennifer M McNiff; Jordan S Pober
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

3.  Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells.

Authors:  Alexander Sasha Krupnick; Andrew E Gelman; Winfried Barchet; Steve Richardson; Friederike H Kreisel; Laurence A Turka; Marco Colonna; G Alexander Patterson; Daniel Kreisel
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

4.  Antibodies to liver sinusoidal endothelial cells modulate immune responses in liver transplantation.

Authors:  X Ge; A Karrar; B-G Ericzon; U Broomé; S Sumitran-Holgersson
Journal:  Transplant Proc       Date:  2005-10       Impact factor: 1.066

Review 5.  GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily.

Authors:  Giuseppe Nocentini; Carlo Riccardi
Journal:  Eur J Immunol       Date:  2005-04       Impact factor: 5.532

6.  Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL.

Authors:  B C Biedermann; J S Pober
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

7.  Single-cell analysis of costimulation by B cells, endothelial cells, and fibroblasts demonstrates heterogeneity in responses of CD4(+) memory T cells.

Authors:  L L Murphy; M M Mazanet; A C Taylor; J Mestas; C C Hughes
Journal:  Cell Immunol       Date:  1999-06-15       Impact factor: 4.868

8.  Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.

Authors:  L Leifeld; C Trautwein; F L Dumoulin; M P Manns; T Sauerbruch; U Spengler
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

9.  Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA.

Authors:  Javier Mestas; Steve P Crampton; Toshiyuki Hori; Christopher C W Hughes
Journal:  Int Immunol       Date:  2005-05-20       Impact factor: 4.823

10.  Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation.

Authors:  M D Denton; C S Geehan; S I Alexander; M H Sayegh; D M Briscoe
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

View more
  62 in total

1.  Polarized granzyme release is required for antigen-driven transendothelial migration of human effector memory CD4 T cells.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  J Immunol       Date:  2014-11-03       Impact factor: 5.422

Review 2.  How leukocytes cross the vascular endothelium.

Authors:  Dietmar Vestweber
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

3.  Blocking MHC class II on human endothelium mitigates acute rejection.

Authors:  Parwiz Abrahimi; Lingfeng Qin; William G Chang; Alfred L M Bothwell; George Tellides; W Mark Saltzman; Jordan S Pober
Journal:  JCI Insight       Date:  2016-01-21

4.  Complement Membrane Attack Complexes Assemble NLRP3 Inflammasomes Triggering IL-1 Activation of IFN-γ-Primed Human Endothelium.

Authors:  Catherine B Xie; Lingfeng Qin; Guangxin Li; Caodi Fang; Nancy C Kirkiles-Smith; George Tellides; Jordan S Pober; Dan Jane-Wit
Journal:  Circ Res       Date:  2019-04-22       Impact factor: 17.367

Review 5.  Inflammation and the blood microvascular system.

Authors:  Jordan S Pober; William C Sessa
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-23       Impact factor: 10.005

Review 6.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

Review 7.  Focus on cardiac pericytes.

Authors:  Stephan Nees; Dominik R Weiss; Gerd Juchem
Journal:  Pflugers Arch       Date:  2013-02-27       Impact factor: 3.657

8.  Transplant rejection and paradigms lost.

Authors:  Terry B Strom
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

9.  Cognate antigen directs CD8+ T cell migration to vascularized transplants.

Authors:  Jeffrey M Walch; Qiang Zeng; Qi Li; Martin H Oberbarnscheidt; Rosemary A Hoffman; Amanda L Williams; David M Rothstein; Warren D Shlomchik; Jiyun V Kim; Geoffrey Camirand; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

10.  TCR-driven transendothelial migration of human effector memory CD4 T cells involves Vav, Rac, and myosin IIA.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.